GENEVA, July 31 -- THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA filed a patent application (US2025/035853) for “USE OF LIPID NANOPARTICLE MRNA FOR TERT SPECIFIC CANCER IMMUNOTHERAPY”. With publication no. WO/2026/010842, here are the other details related to the patent application:
Kind: Correction of entry in Section I of the PCT Gazette [A8]
IPC: A61K 39/00
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....